Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2013 |
| gptkbp:ATCCode |
A16AX09
|
| gptkbp:brand |
gptkb:Ravicti
|
| gptkbp:CASNumber |
611168-24-2
|
| gptkbp:developedBy |
gptkb:Hyperion_Therapeutics
|
| gptkbp:hasMolecularFormula |
C27H41NO6
|
| gptkbp:hasSMILES |
O=C(OCC(COC(=O)CCCC1=CC=CC=C1)COC(=O)CCCC1=CC=CC=C1)CCCC1=CC=CC=C1
|
| https://www.w3.org/2000/01/rdf-schema#label |
glycerol phenylbutyrate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
nitrogen scavenger
|
| gptkbp:metabolism |
phenylacetic acid
phenylacetylglutamine |
| gptkbp:molecularWeight |
475.61 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:relatedTo |
gptkb:sodium_phenylbutyrate
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain fatigue |
| gptkbp:UNII |
7XQY4QOX6O
|
| gptkbp:usedFor |
gptkb:urea_cycle_disorders
|
| gptkbp:bfsParent |
gptkb:Ravicti
|
| gptkbp:bfsLayer |
8
|